Pancreatic ductal adenocarcinoma and edema: reassessing cachexia markers
Irfana Muqbil, Christian Stevens, Muhammad Wasif Saif · 2026
Read Pancreatic ductal adenocarcinoma and edema: reassessing cachexia markers by Irfana Muqbil, Christian Stevens, Muhammad Wasif Saif (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13350619.txt.
Description
Irfana Muqbil and colleagues wrote a 2026 commentary reassessing wasting markers in pancreatic ductal adenocarcinoma, among the deadliest cancers, with true five-year survival in single digits once better-prognosis related tumours are excluded. Most patients arrive late, already losing weight, appetite, and muscle.
The authors engage with work showing body swelling can corrupt scan-based muscle measures, making wasting look better or worse than it is. Many patients are too weakened for the strongest drug combinations, so honest fitness measures decide who can be treated. Rethinking cachexia markers is therefore not academic: it shapes chemotherapy choices and supportive care for a disease with little margin.
Catalog record
| CREATOR | Irfana Muqbil, Christian Stevens, Muhammad Wasif Saif |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9420 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |